MDXG
Price
$6.49
Change
+$0.15 (+2.37%)
Updated
Jun 6 closing price
Capitalization
935.69M
58 days until earnings call
PCVX
Price
$36.99
Change
+$2.19 (+6.29%)
Updated
Jun 6 closing price
Capitalization
4.49B
65 days until earnings call
Interact to see
Advertisement

MDXG vs PCVX

Header iconMDXG vs PCVX Comparison
Open Charts MDXG vs PCVXBanner chart's image
MiMedx Group
Price$6.49
Change+$0.15 (+2.37%)
Volume$372.47K
Capitalization935.69M
Vaxcyte
Price$36.99
Change+$2.19 (+6.29%)
Volume$1.58M
Capitalization4.49B
MDXG vs PCVX Comparison Chart
Loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXG vs. PCVX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXG is a Buy and PCVX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (MDXG: $6.51 vs. PCVX: $31.38)
Brand notoriety: MDXG and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXG: 94% vs. PCVX: 81%
Market capitalization -- MDXG: $935.69M vs. PCVX: $4.49B
MDXG [@Biotechnology] is valued at $935.69M. PCVX’s [@Biotechnology] market capitalization is $4.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXG’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • MDXG’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MDXG and PCVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXG’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • MDXG’s TA Score: 4 bullish, 6 bearish.
  • PCVX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than MDXG.

Price Growth

MDXG (@Biotechnology) experienced а -5.65% price change this week, while PCVX (@Biotechnology) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

MDXG is expected to report earnings on Aug 05, 2025.

PCVX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.49B) has a higher market cap than MDXG($936M). MDXG YTD gains are higher at: -32.328 vs. PCVX (-61.666). MDXG has higher annual earnings (EBITDA): 64.3M vs. PCVX (-448.08M). PCVX has more cash in the bank: 1.75B vs. MDXG (104M). MDXG has less debt than PCVX: MDXG (18.8M) vs PCVX (71.1M). MDXG has higher revenues than PCVX: MDXG (349M) vs PCVX (0).
MDXGPCVXMDXG / PCVX
Capitalization936M4.49B21%
EBITDA64.3M-448.08M-14%
Gain YTD-32.328-61.66652%
P/E Ratio23.46N/A-
Revenue349M0-
Total Cash104M1.75B6%
Total Debt18.8M71.1M26%
FUNDAMENTALS RATINGS
MDXG: Fundamental Ratings
MDXG
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDXGPCVX
RSI
ODDS (%)
Bullish Trend 12 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
80%
Momentum
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
75%
MACD
ODDS (%)
Bearish Trend 12 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
59%
Bearish Trend 13 days ago
71%
Aroon
ODDS (%)
Bearish Trend 12 days ago
77%
Bullish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with INM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-3.84%
INM - MDXG
38%
Loosely correlated
-5.40%
PCVX - MDXG
36%
Loosely correlated
-1.10%
OMER - MDXG
34%
Loosely correlated
-0.95%
CTMX - MDXG
32%
Poorly correlated
+12.94%
FULC - MDXG
32%
Poorly correlated
+8.66%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with RCKT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-1.10%
RCKT - PCVX
44%
Loosely correlated
+6.44%
ORKA - PCVX
43%
Loosely correlated
+0.26%
DNLI - PCVX
43%
Loosely correlated
-1.29%
DYN - PCVX
40%
Loosely correlated
+0.51%
VCEL - PCVX
39%
Loosely correlated
+0.07%
More